Latest News & Insights
Stay Up to Date with Our Community
Featured
September 9, 2024
In a recent article in Endpoints, Astellas highlights its work in gene therapy and commitment to rare diseases, including its...
Loading...
September 9, 2024
In a recent article in Endpoints, Astellas highlights its work in...
September 9, 2024
Latigo Biotherapeutics Inc. ("Latigo"), a clinical-stage biotechnology company developing best-in-class non-opioid...
September 4, 2024
Arsenal Biosciences, Inc. (ArsenalBio), a clinical stage programmable cell therapy company...
July 22, 2024
Latigo Biotherapeutics Inc. (“Latigo”), a clinical-stage biotechnology company developing best-in-class non-opioid...
June 26, 2024
Star Therapeutics, a clinical stage biotechnology company discovering and developing best-in-class...
June 16, 2024
Electra Therapeutics, Inc., a clinical stage biotechnology company developing antibody therapies...
June 7, 2024
Kyverna Therapeutics, Inc. (Kyverna), a patient-centered, clinical-stage biopharmaceutical company focused on...
May 9, 2024
Kate Therapeutics Inc. ("KateTx"), a next-generation gene therapy company, will present...
April 30, 2024
Arsenal Biosciences, Inc. (ArsenalBio), a clinical stage programmable cell therapy company...